Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 27 Issue 4, April 2021

Vascular remodeling in ALS

Although brain perivascular fibroblast cells were not previously considered to be involved in the etiology of amyotrophic lateral sclerosis (ALS), their activity shows a promising early indication of disease symptoms. Månberg and colleagues show that perivascular fibroblast cells become activated in patients with sporadic ALS and in mouse models at an early stage that precedes neuronal loss. The cover artwork by Mattias Karlen shows the location of perivascular fibroblast cells in the neurovascular unit and the formation of an enlarged perivascular space.

See Månberg et al.

Image credit: Mattias Karlen. Cover design: Marina Spence.

Editorial

  • Gene-therapy trials are on the rise, but more needs to be done to understand the long-term risks associated with this type of treatment.

    Editorial

    Advertisement

Top of page ⤴

News Feature

Top of page ⤴

Correspondence

Top of page ⤴

World View

Top of page ⤴

Comment

Top of page ⤴

News & Views

Top of page ⤴

Review Articles

  • A comprehensive review of the current literature on post-acute COVID-19, also referred to as long COVID, its pathophysiology and its organ-specific sequelae highlights the need for multidisciplinary follow-up and care of COVID-19 survivors.

    • Ani Nalbandian
    • Kartik Sehgal
    • Elaine Y. Wan
    Review Article
Top of page ⤴

Brief Communications

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links